Effect of Tirzepatide on Liver Fat Content and Abdominal Adipose Tissue in Patients With Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial
Lancet Diabetes Endocrinol 2022 Apr 22;[EPub Ahead of Print], A Gastaldelli, K Cusi, L Fernández Landó, R Bray, B Brouwers, Á RodríguezFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.